Final Results of a Phase II Clinical Trial of Weekly Docetaxel in Combination with Capecitabine in Anthracycline-Pretreated Metastatic Breast Cancer-Reference-Cited by-同舟云学术

Final Results of a Phase II Clinical Trial of Weekly Docetaxel in Combination with Capecitabine in Anthracycline-Pretreated Metastatic Breast Cancer

Published:2004-10 Issue:4 Volume:5 Page:287-292
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Mackey John R.,Tonkin Katia S.,Koski Sheryl L.,Scarfe Andrew G.,Smylie Michael G.B.,Joy Anil A.,Au Heather-Jane,Bodnar Dianne M.,Soulieres Denis,Smith Stephanie W.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference21 articles.

1. Canadian Cancer Statistics 2004;National Cancer Institute of Canada,2004

2. Chemotherapy of breast cancer: a historical perspective;Hortobagyi;Semin Oncol,1997

3. Results and long term followup for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy: a reference;Rahman;Cancer,1999

4. Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer;Nabholtz;Oncology,1997

5. Docetaxel vs doxorubicin in metastatic breast cancer resistant to alkylating chemotherapy;Chan;Oncology,1997

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Classical Taxane versus the New Generation, Nab-Paclitaxel Chemotherapy in the Treatment of Breast Cancer;MOJ Cell Science & Report;2017-05-30

2. A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer;Cancer Chemotherapy and Pharmacology;2012-06-06

3. Phase II Trial of a Metronomic Schedule of Docetaxel and Capecitabine with Concurrent Celecoxib in Patients with Prior Anthracycline Exposure for Metastatic Breast Cancer;Current Oncology;2012-04-01

4. Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancer;Annals of Oncology;2011-03

5. Capecitabine combined with weekly docetaxel in Chinese patients > 65 years with anthracycline-resistant metastatic breast cancer;CHINESE MED J-PEKING;2010